Adverse events and residual lesion rate after cold endoscopic mucosal resection of serrated lesions ≥10 mm

Gastrointest Endosc. 2021 Mar;93(3):654-659. doi: 10.1016/j.gie.2020.08.032. Epub 2020 Sep 3.

Abstract

Background and aims: Cold EMR is being increasingly used for large serrated lesions. We sought to measure residual lesion rates and adverse events after cold EMR of large serrated lesions.

Methods: In a single academic center, we retrospectively examined a database of serrated class lesions ≥10 mm removed with cold EMR for safety and efficacy.

Results: Five hundred sixty-six serrated lesions ≥10 mm in size were removed from 312 patients. We successfully contacted 223 patients (71.5%) with no reported serious adverse events that required hospitalization, repeat endoscopy, or transfusion. The residual lesion rate per lesion at first follow-up colonoscopy was 18 of 225 (8%; 95% confidence interval, 5-12.1). Lesions with residual were larger at polypectomy compared with lesions without recurrence (median, 23 mm versus 16 mm, P = .017).

Conclusion: Cold EMR appears to be safe and effective for the removal of large serrated lesions.

MeSH terms

  • Colonic Polyps* / surgery
  • Colonoscopy
  • Endoscopic Mucosal Resection* / adverse effects
  • Humans
  • Retrospective Studies